Digital Subtraction Angiography Market Overview

The digital subtraction angiography market size is anticipated to rise at a CAGR of 7% from 2022 to 2032, from a value of US$ 394 Mn in 2022 to US$ 775.06 Mn by 2032. Major factors propelling the demand for digital subtraction angiography are:

  • The sales of digital subtraction angiography are anticipated to rise as it is frequently utilized in the evaluation of vascular bypass grafts, aortic arch abnormalities, and aortic contraction in addition to its usage in carotid arteries.
  • Key players in the digital subtraction angiography (DSA) market are investing heavily in the latest technologies or upgrading the systems as it is a computer-aided technology, much like CT scanning that needs to be updated regularly.
  • Companies can develop innovative diagnostic imaging techniques due to the quick development of digital subtraction angiography (DSA) technology.
  • Digital subtraction angiography, therefore, has the potential to considerably enhance the diagnostic screening and postoperative assessment skills of the radiologist and physician.
  • Due to digital subtraction angiography's increased sensitivity and specificity for diagnostic reasons, earlier non-invasive techniques (such as periorbital ultrasonography and thermography) may be less frequently used.
  • The diagnosis of anomalies such as ulcerated plaques, extracranial occlusions, stenosis, and aneurysms is also made easier by digital subtraction angiography.
Attributes Details
Digital Subtraction Angiography Market Value (2022) US$ 394 Million
Digital Subtraction Angiography Market Forecast Value (2032) US$ 775.06 Million
Digital Subtraction Angiography Market CAGR (2022 to 2032) 7%

Digital subtraction angiography (DSA) is a digital radiography, digital fluoroscopy, and photo electronic imaging techniques intended for the diagnosis and treatment of various vascular disorders. Digital subtraction angiography is subtraction of two images that are obtained before and after contrast media is administered into the patient for the purpose of angiography.

The digital subtraction angiography (DSA) systems were introduced in the late 1970s to obtain clear images of arteries, veins and organs of the body using complex computerized X-ray equipment. Digital subtraction angiography also facilitates to detect abnormalities such as ulcerated plaques, extra-cranial occlusions, stenosis and aneurysms.

In addition to its regular application in carotid arteries this technique is extensively used in the evaluation of vascular by-pass grafts, aortic arch anomalies and aortic coarctation. Recently developed three-dimensional DSA has been proved to be enhanced in the detection and delineation of intracranial aneurysms, with lower radiation dose, less contrast use, and shorter procedural time compared to two dimensional DSA.

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

Digital Subtraction Angiography Market:  Drivers & Restraints

Global digital subtraction angiography market is estimated to show a healthy growth in the coming years due to increasing incidence of cardiovascular diseases. Major driver for the global subtraction angiography market are technological advancements, increasing number of launch of new products with lower iodine dose contrast medium, novel gadolinium contrast medium based, advanced noise reduction imagining technology based DSA products, etc.

Moreover, increasing awareness of people for accurate and precise diagnosis is an additional factor which is anticipated to drive the global digital subtraction angiography market. However, relative infrequency of serious reactions to intravenously administered contrast material, price and reimbursement issues and stringent regulatory approvals are major factors that can hinder the global digital subtraction angiography market growth over the forecast period.

Digital Subtraction Angiography Market:  Overview

Global Digital Subtraction Angiography market is largely concentrated in North America, which is expected to account for largest share of the market followed by Europe. The CAGR of the global digital subtraction angiography market in USA and Europe regions are expected to be slower due to market saturation as compared to Asia Pacific regions.

Asian countries such as China and India are estimated to witness notable growth rate due to large patient population with high cardiovascular disease prevalence. By technology type, noise reduction imagining technology is dominant segment globally as compared to other traditional technologies due to its dose-reduction and high quality images.

By end use, the hospitals and diagnostic center segments are projected to account for around 50% share in the global digital subtraction angiography market and the trend is forecast to continue through 2025.

Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Digital Subtraction Angiography Market:  Key Players

The global digital subtraction angiography market key players are Abbott Vascular, Boston Scientific Corporation, Cordis Corporation, DMS Group, Eigen LLC, GE Healthcare, Medtronic, Inc., Siemens AG, St. Jude Medical, Shimadzu Corporation, Philips Healthcare, Toshiba Corporation, etc.

The report covers exhaustive analysis on

  • Market Segments
  • Market Dynamics
  • Market Size
  • Supply & Demand
  • Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Technology
  • Value Chain

Get the data you need at a Fraction of the cost

Personalize your report by choosing insights you need
and save 40%!

Regional analysis includes

  • North America (U.S., Canada)
  • Latin America (Mexico, Brazil)
  • Western Europe (Germany, Italy, France, U.K, Spain, Nordic countries, BENELUX)
  • Eastern Europe (Poland, Russia)
  • Asia Pacific (China, India, ASEAN, Australia & New Zealand)
  • Japan
  • Middle East and Africa (GCC and S. Africa)

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain.

The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Digital Subtraction Angiography Market: Segmentation

The global digital subtraction angiography market is classified on the basis of product type, technology, indication, procedures, end user and region.

Based on product type, the global digital subtraction angiography market is segmented into the following:

  • Instruments
  • Contrast Medium

Based on technology, the global digital subtraction angiography market is segmented into the following:

  • Traditional Imagining Technology
  • Noise Reduction Imagining Technology

Based on procedures, the global digital subtraction angiography market is segmented into the following:

  • Intra-Arterial Digital Subtraction Angiography
  • Intravenous Digital Subtraction Angiography

Based on indication, the global digital subtraction angiography market is segmented into the following:

  • Carotid Artery Disorders
  • Thoracic Vascular Disorders
  • Abdominal Aorta Disorders
  • Intracranial Aorta Disorders
  • Pulmonary Aorta Disorders
  • Peripheral Aorta Disorders
  • Renal Aorta Disorders
  • Extracranial Carotid Occlusive Disorders
  • Other Arterial and Venous Occlusions

Based on end user, the global digital subtraction angiography market is segmented into the following:

  • Medium-sized and Large Hospitals
  • Diagnostic Centers
  • Outpatient Clinics
  • Laboratories in Universities
Table of Content
  • 1. Executive Summary
  • 2. Industry Introduction, including Taxonomy and Market Definition
  • 3. Market Trends and Success Factors, including Macro-economic Factors, Market Dynamics, and Recent Industry Developments
  • 4. Global Market Demand Analysis and Forecast, including Historical Analysis and Future Projections
  • 5. Pricing Analysis
  • 6. Global Market Analysis and Forecast
    • 6.1. Product Type
    • 6.2. Based On Technology
    • 6.3. Based On Procedures
    • 6.4. Based On Indication
    • 6.5. Based On End User
  • 7. Global Market Analysis and Forecast, By Product Type
    • 7.1. Instruments
    • 7.2. Contrast Medium
  • 8. Global Market Analysis and Forecast, By Based On Technology
    • 8.1. Traditional Imaging Technology
    • 8.2. Noise Reduction Imaging Technology
  • 9. Global Market Analysis and Forecast, By Based On Procedures
    • 9.1. Intra-Arterial
    • 9.2. Intravenous
  • 10. Global Market Analysis and Forecast, By Based On Indication
    • 10.1. Carotid Artery Disorders
    • 10.2. Thoracic Vascular Disorders
    • 10.3. Abdominal Aorta Disorders
    • 10.4. Intracranial Aorta Disorders
    • 10.5. Pulmonary Aorta Disorders
    • 10.6. Peripheral Aorta Disorders
    • 10.7. Renal Aorta Disorders
    • 10.8. Extracranial Carotid Occlusive Disorders
    • 10.9. Other Arterial and Venous Occlusions
  • 11. Global Market Analysis and Forecast, By Based On End User
    • 11.1. Medium-sized and Large Hospitals
    • 11.2. Diagnostic Centers
    • 11.3. Outpatient Clinics
    • 11.4. Laboratories in Universities
  • 12. Global Market Analysis and Forecast, By Region
    • 12.1. Latin America
    • 12.2. Western Europe
    • 12.3. Eastern Europe
    • 12.4. Asia Pacific
    • 12.5. Japan
    • 12.6. Middle East and Africa
  • 13. Latin America Sales Analysis and Forecast, by Key Segments and Countries
  • 14. Western Europe Sales Analysis and Forecast, by Key Segments and Countries
  • 15. Eastern Europe Sales Analysis and Forecast, by Key Segments and Countries
  • 16. Asia Pacific Sales Analysis and Forecast, by Key Segments and Countries
  • 17. Japan Sales Analysis and Forecast, by Key Segments and Countries
  • 18. Middle East and Africa Sales Analysis and Forecast, by Key Segments and Countries
  • 19. Sales Forecast by Product Type, Based On Technology, Based On Procedures, Based On Indication, and Based On End User for 30 Countries
  • 20. Competition Outlook, including Market Structure Analysis, Company Share Analysis by Key Players, and Competition Dashboard
  • 21. Company Profile
    • 21.1. Boston Scientific Corporation
    • 21.2. Cordis Corporation
    • 21.3. DMS Group
    • 21.4. Eigen LLC
    • 21.5. GE Healthcare
    • 21.6. Medtronic Inc.
    • 21.7. Siemens AG
    • 21.8. St. Jude Medical
    • 21.9. Shimadzu Corporation
    • 21.10. Philips Healthcare
    • 21.11. Toshiba Corporation

Explore Healthcare Insights

View Reports
Future Market Insights

Digital Subtraction Angiography Market

Schedule a Call